Sign in

CIK 0001231457 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

GENELUX Corp

Sign in to watch
Ticker
GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
805-267-9889
Business address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$155,693
in 6 filings

Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 71 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-16 Yu Yong Chief Scientific Officer Grant or award +119,318 269,024
2026-06-16 Smither John W Director Grant or award +28,409 103,403
2026-06-16 Smither John W Director Grant or award · Stock Option (Right to Buy) +31,566 31,566
2026-06-03 Smalling Ralph Head of Regulatory Sale −192 $2.93 $563 67,611
2026-06-01 Thomas John Director Sale 10b5-1 −10,000 $2.98 $30K 472,784
2026-05-11 Cappello Joseph Chief Technical Officer Sale −605 $2.97 $2K 154,549
2026-05-11 Yu Yong Chief Scientific Officer Sale −605 $2.97 $2K 149,706
2026-05-11 Zindrick Thomas President and CEO Sale −2,798 $2.94 $8K 532,051
2026-05-11 Smalling Ralph Head of Regulatory Sale −270 $2.98 $804 67,803
2026-03-25 Smalling Ralph Head of Regulatory Sale −240 $2.51 $602 68,073
2026-03-24 Smalling Ralph Head of Regulatory Sale −345 $2.42 $835 68,313
2026-03-24 Cappello Joseph Chief Technical Officer Sale −906 $2.42 $2K 155,154
2026-03-24 Yu Yong SVP, Clinical Development Sale −906 $2.42 $2K 144,938
2026-03-24 Zindrick Thomas President and CEO Sale −3,582 $2.42 $9K 534,849
2026-03-02 Thomas John Director Sale 10b5-1 −10,000 $2.90 $29K 482,784
2026-01-02 Litten Jason Chief Medical Officer Grant or award · Stock Option (Right to Buy) +275,000 275,000
2025-12-05 Smalling Ralph Head of Regulatory Sale −165 $4.69 $774 68,658
2025-12-01 Thomas John Director Sale 10b5-1 −10,000 $5.00 $50K 492,784
2025-11-17 Zindrick Thomas President and CEO Sale −4,509 $5.37 $24K 538,431
2025-11-17 Yu Yong SVP, Clinical Development Sale −973 $5.37 $5K 145,844

Page 2 of 9 · 170 trades